False-negative apraclonidine testing in acute Horner syndrome.

[1]  D. Satterfield,et al.  Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants. , 2006, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[2]  D. Lu,et al.  Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination. , 2006, American journal of ophthalmology.

[3]  D. Lu,et al.  Comparing efficacies of 0.5% apraclonidine with 4% cocaine in the diagnosis of horner syndrome in pediatric patients. , 2006, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[4]  T. Kansu,et al.  The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis , 2005, British Journal of Ophthalmology.

[5]  S. Levy,et al.  The use of apraclonidine in the diagnosis of horner syndrome in pediatric patients. , 2004, Archives of ophthalmology.

[6]  Sandra M. Brown,et al.  The utility of 0.5% apraclonidine in the diagnosis of horner syndrome. , 2005, Archives of ophthalmology.

[7]  C. Crosson,et al.  Ocular effects of apraclonidine in Horner syndrome. , 2000, Archives of ophthalmology.

[8]  H. S. Thompson,et al.  Adrenergic mydriasis in Horner's syndrome. Hydroxyamphetamine test for diagnosis of postganglionic defects. , 1971, American journal of ophthalmology.